UBE2I is a therapeutic target in cholangiocarcinoma, researchers find
March 7, 2025
Cholangiocarcinoma includes several biliary malignant tumors that have poor prognosis. Post-translational modifications in proteins lead to abnormal protein dynamics and disturbances that may cause pathology.